| Literature DB >> 20956338 |
Giulia Tonel1, Curdin Conrad, Ute Laggner, Paola Di Meglio, Katarzyna Grys, Terrill K McClanahan, Wendy M Blumenschein, Jian-Zhong Qin, Hong Xin, Elizabeth Oldham, Robert Kastelein, Brian J Nickoloff, Frank O Nestle.
Abstract
Interleukin-23 is a key cytokine involved in the generation of Th17 effector cells. Clinical efficacy of an anti-p40 mAb blocking both IL-12 and IL-23 and disease association with single nucleotide polymorphisms in the IL23R gene raise the question of a functional role of IL-23 in psoriasis. In this study, we provide a comprehensive analysis of IL-23 and its receptor in psoriasis and demonstrate its functional importance in a disease-relevant model system. The expression of IL-23 and its receptor was increased in the tissues of patients with psoriasis. Injection of a mAb specifically neutralizing human IL-23 showed IL-23-dependent inhibition of psoriasis development comparable to the use of anti-TNF blockers in a clinically relevant xenotransplant mouse model of psoriasis. Together, our results identify a critical functional role for IL-23 in psoriasis and provide the rationale for new treatment strategies in chronic epithelial inflammatory disorders.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20956338 PMCID: PMC3776381 DOI: 10.4049/jimmunol.1001538
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422